LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.03 | 21.74 | 1085 | 6155 | 0.1763 | 0.6162 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.03 | 21.74 | 6405 | 6155 | 1.0406 | 1.0098 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.03 | 21.74 | 10 | 6155 | 0.0016 | -0.0909 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.03 | 21.74 | 7925 | 6155 | 1.2875 | 1.0630 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.00 | 21.74 | 989 | 6081 | 0.1626 | 0.5995 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.00 | 21.74 | 6521 | 6081 | 1.0723 | 1.0172 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.00 | 21.74 | 2 | 6081 | 0.0003 | -0.2544 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 88.00 | 21.74 | 8106 | 6081 | 1.3329 | 1.0720 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.97 | 21.74 | 1081 | 6084 | 0.1777 | 0.6170 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.97 | 21.74 | 6725 | 6084 | 1.1053 | 1.0248 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.97 | 21.74 | 8 | 6084 | 0.0013 | -0.1157 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.97 | 21.74 | 8374 | 6084 | 1.3763 | 1.0802 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.94 | 21.74 | 1073 | 6121 | 0.1753 | 0.6147 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.94 | 21.74 | 6883 | 6121 | 1.1243 | 1.0290 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.94 | 21.74 | 8 | 6121 | 0.0013 | -0.1156 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.94 | 21.74 | 8588 | 6121 | 1.4028 | 1.0849 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.92 | 21.74 | 1123 | 6070 | 0.1850 | 0.6250 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.92 | 21.74 | 7114 | 6070 | 1.1720 | 1.0394 | MN20160310_N01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.92 | 21.74 | 10 | 6070 | 0.0016 | -0.0911 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 93.92 | 21.74 | 8800 | 6070 | 1.4498 | 1.0935 | MN20160310_N01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.24 | 21.74 | 333 | 183 | 1.8140 | 1.4269 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.24 | 21.74 | 412 | 183 | 2.2444 | 1.6007 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 2.24 | 21.74 | 1 | 183 | 0.0054 | -0.6323 | MN20160310_N01 | L08 |